High‐Density Dynamic Culture of Neonatal Porcine Islets Improves Islet Recovery and Function Post‐Transplantation
Xenotransplantation · 2026-11 · 33 (6)
DOI: 10.1111/xen.70181 ↗Abstract
ABSTRACT Introduction Type 1 diabetes (T1D) results from autoimmune destruction of pancreatic β‐cells, necessitating lifelong exogenous insulin therapy. Scalable β‐cell replacement strategies are needed to reproducibly increase ß cell production. Neonatal porcine islets (NPIs) are a promising xenogeneic source of ß cells; however, limited manufacturing scalability hinders clinical translation. This study optimizes a dynamic culture system to assess its potential for scalable NPIs production for clinical translation. Methods NPIs were cultured under three conditions: static suspension and dynamic suspension in a PBS Mini Vertical‐Wheel bioreactor at 4.5K (Bio 4.5) and 6.0K (Bio 6.0) NPIs/ml. NPI recovery and composition were evaluated via total DNA, insulin content, and β‐cell recovery. Functional and structural assessments included glucose‐stimulated insulin secretion (GSIS), mitochondrial oxygen consumption rate (OCR), and immunohistochemistry. Streptozotocin‐induced diabetic B6.129S7‐ Rag1 tm1Mom /J mice received transplants of NPIs from static or Bio 6.0 cultures. Metabolic function was assessed by non‐fasting glucose and IPGTT, alongside histological analysis of explanted grafts. Results Bio 6.0 NPIs demonstrated significantly higher DNA ( p < 0.001), insulin content (p < 0.0001), and β cell recovery (p < 0.01), with increased β‐cells per pancreas ( p < 0.05), smaller aggregate size ( p < 0.0001), and improved morphology. In vivo, Bio 6.0 grafts achieved faster glycemic normalization ( p < 0.05) and improved IPGTT outcomes at 10 weeks ( p < 0.05). Histology confirmed cohesive architecture and strong insulin staining. Conclusion High‐density bioreactor culture enhances NPIs performance and the potential for scalability, improving diabetes reversal and supporting clinical translation for β cell replacement therapy.
EUVIMED